Phase 1 trial of the anti-LAG3 antibody favezelimab plus pembrolizumab in advanced gastric cancer.
- Resource Type
- Article
- Authors
- Rha, Sun Young; Miller, Wilson H.; de Miguel, María José; Im, Seock-Ah; Lugowska, Iwona; Wermke, Martin; Kotani, Daisuke; Bauer, Todd Michael; Takashima, Atsuo; Palcza, John; Chaney, Marya F.; Dobrenkov, Konstantin; Garralda, Elena
- Source
- Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p394-394, 1p
- Subject
- Language
- ISSN
- 0732183X